language Türkçe
Meeting Abstract 2021 · 0 citations

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Ozbalak, Murat, Akay, Olga Meltem, Pehlivan, Mustafa, Yildiz, Birol, Uzay, Ant, Yigenoglu, Tugce Nur, Elverdi, Tugrul, Kaynar, Leylagul, Ayyildiz, Orhan, Hindilerden, Ipek Yonal, Goksoy, Hasan Sami, Guner, Sebnem Izmir, Gunes, Ahmet Kursad, Sonmez, Mehmet, Yuksel, Meltem Kurt, Bozdag, Sinem Civriz, Ozkurt, Zubeyde Nur, Toptas, Tayfur, Dogu, Mehmet Hilmi, Salim, Ozan, Saydam, Guray, Yavasoglu, Irfan, Ayli, Meltem, Ozet, Gulsum, Albayrak, Murat, Atesoglu, Elif Birtas, Toprak, Selami K., Yildirim, Rahsan, Mehtap, Ozgur, Besisik, Sevgi Kalayoglu, Nalcaci, Meliha, Altuntas, Fevzi, Ferhanoglu, Burhan

Abstract

No abstract available for this publication.

Keywords
relapsed and refractory Hodgkin lymphoma brentuximab vedotin autologous stem cell transplantation consolidation
WoS Categories
Oncology Hematology
Citation
Journal
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Year
2021
Volume
21
Pages
S368-S369
ISSN
2152-2650
eISSN
2152-2669
WoS UID
WOS:000691910500283